SMAD3 and nonpapillary renal cell carcinoma: In ccRCC cells, lnc-TSI specifically inhibited the phosphorylation of Smad3 and subsequent EMT by binding with the MH2 domain of Smad3 to block the interaction between Smad3 and TβRI.